Contraception
Volume 81, Issue 4 , Pages 309-315, April 2010

Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women

  • Ana Cristina S. Rebelo

      Affiliations

    • Universidade Federal de São Carlos, 13565905 São Carlos-SP, Brazil
    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
    • Corresponding Author InformationCorresponding author. Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, Rodovia do Açúcar, km 156; 13400911 Piracicaba-SP, Brazil. Fax: +55 19 3124 1515x1558.
  • ,
  • Roberta S. Zuttin

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
  • ,
  • Rozangela Verlengia

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
  • ,
  • Marcelo de C. Cesar

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
  • ,
  • Marcos Felipe Silva de Sá

      Affiliations

    • Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Ginecologia e Obstetrícia, 14048900 Riberão Preto-SP, Brazil
  • ,
  • Ester da Silva

      Affiliations

    • Universidade Federal de São Carlos, 13565905 São Carlos-SP, Brazil
    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil

Received 6 October 2009; received in revised form 3 November 2009; accepted 9 November 2009. published online 07 December 2009.

Abstract 

Background

The purpose of this study was to evaluate the effect of long-term use of oral contraceptives (OC) containing 0.20 mg of ethinylestradiol (EE) combined with 0.15 mg of gestodene (GEST) on the peak aerobic capacity and at the anaerobic threshold (AT) level in active and sedentary young women.

Study Design

Eighty-eight women (23±2.1 years old) were divided into four groups — active-OC (G1), active-NOC (G2), sedentary-OC (G3) and sedentary-NOC (G4) — and were submitted to a continuous ergospirometric incremental test on a cycloergometer with 20 to 25 W min−1 increments. Data were analyzed by two-way ANOVA with Tukey post hoc test. Level of significance was set at 5%.

Results

The OC use effect for the variables relative and absolute oxygen uptake V̇O2 mL kg−1 min−1; V̇O2, L min−1, respectively), carbon dioxide output (V̇CO2, L min−1), ventilation (VE, L min−1), heart rate (HR, bpm), respiratory exchange ratio (RER) and power output (W) data, as well as the interaction between OC use and exercise effect on the peak of test and at the AT level did not differ significantly between the active groups (G1 and G2) and the sedentary groups (G3 and G4). As to the exercise effect, for all variables studied, it was noted that the active groups presented higher values for the variables V̇O2, V̇CO2, VE and power output (p<.05) than the sedentary groups. The RER and HR were similar (p>.05) at the peak and at the AT level between G1 vs. G3 and G2 vs. G4.

Conclusions

Long-term use of OC containing EE 0.20 mg plus GEST 0.15 mg does not affect aerobic capacity at the peak and at the AT level of exercise tests.

Keywords: Oral contraceptive, Ethinylestradiol, Gestodene, Aerobic capacity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This research was supported by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Process no. 370448/2007-3) and FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, Process no. 2006/56788-1).

PII: S0010-7824(09)00489-2

doi:10.1016/j.contraception.2009.11.005

Contraception
Volume 81, Issue 4 , Pages 309-315, April 2010